Lockheed Martin: “…I do not want to get in the way of the Palantir buzz saw because that’s very close to Elon Musk.”
ADMA Biologics: “I don’t have a catalyst…I would wait for it to come down before I would pull the trigger.”
Novocure: “…I just think that they should be making money…Let’s see some money made by Novocure and then we can get behind it.”
Keysight: “We want this one…Terrific business, niche business. I like it, and I think you should own it, and I think you should buy it.”
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? [email protected]